drugset / Trial / NCT01145885
BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Investigation of absorption, distribution, metabolism and excretion (ADME) and assessment of safety, tolerability and preliminary therapeutic effects of \[14C\]volasertib in patients with advanced solid tumours.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-11
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Volasertib | Small molecule | 300 mg | Intravenous |